The GI and Liver Summit will deliver focused, educational updates highlighting clinically relevant advances in the management of patients with chronic liver disease (CLD) and gastrointestinal (GI) disorders to healthcare providers. It will feature an interactive format to enhance the educational impact. The conference will deliver emerging science and incorporate expert opinions on best practices for the diagnosis and management of patients with CLD and GI disorders.
 

The faculty will review state-of-the-art developments in GI disorders and CLD, including gastroparesis (GP), inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), diet and GI cancer, C. difficile, hepatocellular carcinoma (HCC), cirrhosis, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH).
 

The conference will deliver emerging scientific findings and incorporate expert opinions on best practices for the diagnosis and management of patients with CLD and GI disorders.